The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model (Q58447913)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Quan Shang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gerald Salen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Guorong Xu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Matthew K Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Monica Saumoy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

26 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Gastrointestinal and Liver Physiology

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

G815-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

The 'forgotten' bile acid sequestrants: is now a good time to remember?

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Identification of membrane-type receptor for bile acids (M-BAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00295.2011

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00295.2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22281473%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference